English | Español
Patient Daily | Jan 13, 2026

Biotech investors predict active dealmaking and broader focus for 2026
Patient Daily | Jan 13, 2026

Analysts anticipate rebound for biopharma venture capital after late-2025 surge
Patient Daily | Jan 13, 2026

FDA rejects Vanda’s bid for Hetlioz approval in treating jet lag
Patient Daily | Jan 13, 2026

Eli Lilly acquires Ventyx Biosciences for $1.2B; announces cancer therapy pact with InduPro
Patient Daily | Jan 13, 2026

Parabilis secures $305M to advance cancer drug amid biotech fundraising surge
Patient Daily | Jan 13, 2026

Penn researchers develop gene therapy aimed at non-addictive chronic pain relief
Patient Daily | Jan 13, 2026

TU Graz researchers find espresso effective for electron microscopy staining
Patient Daily | Jan 13, 2026

UCLA receives $7.3 million in state funding for cannabis research

Trending
+ Pharmaceuticals
Patient Daily | Jun 18, 2026

FDA seen as more flexible under acting commissioner Kyle Diamantas
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Pharmaceuticals
Patient Daily | Jun 16, 2026

Intellia gene editing therapy shows strong results in hereditary angioedema study
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

PwC reports strong biopharma M&A activity as sector shifts to precision science